How Are Drug Companies Trying to Combat the Ability of the BCL-2

Multiple Choice

How are drug companies trying to combat the ability of the BCL-2 gene to lower the effectiveness of chemotherapy?

A) They are trying to develop drugs that stabilize cancer cells.
B) They are trying to develop drugs that make cancer cells more likely to undergo apoptosis.
C) They are trying to develop drugs that cause cancer cells to revert to normal embryonic cells.
D) They are trying to develop drugs that cause cancer cells to dedifferentiate.
E) They are trying to develop drugs that cause cancer cells to differentiate.